Clinical
Trials of Interest
NOTE: By
definition, clinical trials are investigational and it is therefore
not known if the goals of treatments will be realized.
This is a work in
progress. Click here
to send an email with your suggestions
Perhaps the sheer number of trials for lymphoma is an obstacle to enrollment? That, and the complexity of evaluating each and how it may relate to one's circumstance and treatment goals.
Here we list studies that appear to answer important clinical
questions, and, potentially, the clinical needs of patients.
We believe it's prudent to consider investigational therapies when the condition you face is life-threatening and standard therapies do
not cure. However, it does not follow that investigational therapies are necessarily safer or more effective than existing therapies.
Therefore, you must read the Informed Consent documents carefully, and seek objective opinions and the guidance of your treating physician.
You do not need your doctor’s permission to review clinical trials, contact clinical investigators, or participate in clinical trials.
However, it is best to request that the investigator consult your treating physician, and for you to consult other experts about the potential risks and benefits of clinical trials you
are considering.
Related
Resources
